GeneBact Biotechnologies, Inc. a biopharmaceutical company, manufactures diagnostic tests for detecting mastitis in dairy cattle, a disease estimated to cost U.S. dairy farmers $2 billion annually. GeneBact also is developing and marketing several animal health products that don't rely on traditional chemical antibiotics. The "biorational" approach draws on natural disease-fighting processes to control bacteria, viruses and cancer
